Ypsomed Holding AG (XSWX:YPSN) ROC %: 25.21% (As of Mar. 2026)


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
91 GF Score
Price CHF353.00
GF Value CHF397.48
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ypsomed Holding AG ROC %?

Ypsomed Holding AG XSWX:YPSN +1.91% 91 ROC % is 25.21% as of Mar. 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 91/100 and a GF Value™ of CHF397.48 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Ypsomed Holding AG's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 25.21%.

As of today (2026-06-25), Ypsomed Holding AG's WACC % is 5.44%. Ypsomed Holding AG's ROC % is 18.38% (calculated using TTM income statement data). Ypsomed Holding AG generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Ypsomed Holding AG  (XSWX:YPSN) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Ypsomed Holding AG's WACC % is 5.44%. Ypsomed Holding AG's ROC % is 18.38% (calculated using TTM income statement data). Ypsomed Holding AG generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Ypsomed Holding AG ROC % Related Terms


Ypsomed Holding AG ROC % Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG ROC % Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.35 6.60 8.16 7.67 17.59

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.40 5.97 8.89 11.88 25.21
XSWX:YPSN
91GF Score
Ypsomed Holding AG XSWX:YPSN
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG ROC % Calculation

Ypsomed Holding AG's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=246.075 * ( 1 - 7.9% )/( (1329.765 + 1247.62)/ 2 )
=226.635075/1288.6925
=17.59 %

where

Invested Capital(A: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1330.341 - 69.814 - ( 36.495 - max(0, 496.186 - 426.948+36.495))
=1329.765

Invested Capital(A: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1346.597 - 78.359 - ( 28.559 - max(0, 300.539 - 321.157+28.559))
=1247.62

Ypsomed Holding AG's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=337.94 * ( 1 - 11.61% )/( (1122.109 + 1247.62)/ 2 )
=298.705166/1184.8645
=25.21 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1208.679 - 50.269 - ( 36.301 - max(0, 251.676 - 369.986+36.301))
=1122.109

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1346.597 - 78.359 - ( 28.559 - max(0, 300.539 - 321.157+28.559))
=1247.62

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 25.21% mean?
Ypsomed Holding AG (XSWX:YPSN) has a ROC % of 25.21% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Ypsomed Holding AG and its competitors.
Is Ypsomed Holding AG's ROC % too high?
Ypsomed Holding AG's current ROC % is 25.21%. The Medical Devices & Instruments industry median ROC % is 1.27. Ypsomed Holding AG's value of 25.21% is 1885% above this industry median. Overall, Ypsomed Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's ROC % compare to ISRG and BDX?
Ypsomed Holding AG's ROC % of 25.21% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROC % is 1.27. Ypsomed Holding AG's value of 25.21% is 1885% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Devices & Instruments company?
The median ROC % among Medical Devices & Instruments companies is 1.27, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current ROC % of 25.21% is 1885% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median ROC % is 1.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current ROC % is 25.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF397.48, compared to a current price of CHF353.00 — trading 11.2% below its estimated fair value. The current ROC % is 25.21% and 1885% above the Medical Devices & Instruments industry median of 1.27. Ypsomed Holding AG's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current ROC % is 25.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF353.00 is trading 11.2% below its estimated GF Value™ of CHF397.48. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:YPSN:

  • ROC %: 25.21%
  • GF Value™: CHF397.48 vs. price of CHF353.00 (11.2% below fair value)
  • GF Score™: 91/100 with 3 warning signs
  • Industry Position: 1885% above the Medical Devices & Instruments median

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
91GF Score

Get the complete analysis for XSWX:YPSN

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF353.00
Price
CHF397.48
GF Value